FDA Inspection 1190557 — Grifols Biomat USA, Inc.
The FDA completed an inspection of Grifols Biomat USA, Inc. on Nov 9, 2022 in Provo, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 9, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Provo, UT (United States)